基础医学与临床 ›› 2026, Vol. 46 ›› Issue (7): 950-956.doi: 10.16352/j.issn.1001-6325.2026.07.0950

• 研究论文 • 上一篇    下一篇

ALKBH5通过调控Fdx1表达改善单侧输尿管梗阻模型小鼠肾间质纤维化

侯冬华1, 吴琦2, 梁慧3, 包娜娜1, 吕慧妍2, 岱德羽4, 张蕾1*   

  1. 哈尔滨医科大学附属第一医院 1.血液净化科;2.肾内科;3.中心实验室;4.呼吸科,黑龙江 哈尔滨 150001
  • 收稿日期:2025-06-06 修回日期:2025-09-24 发布日期:2026-06-23
  • 通讯作者: *Zhllb1996@163.com
  • 基金资助:
    哈尔滨医科大学附属第一医院科研创新基金(2023B16);哈尔滨医科大学肝脾外科教育部重点实验室开放课题(GPKF202311)

ALKBH5 ameliorates renal interstitial fibrosis in mouse models with unilateral ureteral obstruction by regulating the expression of Fdx1

HOU Donghua1, WU Qi2, LIANG Hui3, BAO Nana1, LYU Huiyan2, DAI Deyu4, ZHANG Lei1*   

  1. 1. Department of Hematology Purification; 2. Department of Nephrology; 3. Central Laboratory; 4. Department of Respiratory Medicine; the First Affiliated Hospital of Harbin Medical University; Harbin 150001, China
  • Received:2025-06-06 Revised:2025-09-24 Published:2026-06-23
  • Contact: *Zhllb1996@163.com

摘要: 目的 探讨m6A RNA去甲基化酶烷化修复同源物5(ALKBH5)调控铜死亡相关基因铁氧还蛋白1(Fdx1)表达对单侧输尿管梗阻(UUO)模型小鼠肾间质纤维化(RIF)的影响。方法 将UUO模型小鼠随机分为模型组(UUO组)、阴性对照组(LV5-vector组)、ALKBH5过表达组(LV5-ALKBH5组)、LV5-vector+FDX1激活剂(Elesclomol)组、LV5-ALKBH5+Elesclomol组,每组12只。另取12只健康小鼠作为对照组(control组)。ELISA试剂盒检测血清炎性因子水平;采用HE、Masson染色观察肾脏组织病理变化和纤维化情况;RT-qPCR检测肾脏组织上皮细胞-间质转化(EMT)相关基因及Alkbh5、Fdx1 mRNA表达;蛋白质免疫印迹检测ALKBH5、FDX1蛋白表达。结果 与control组相比,UUO组小鼠的肾脏组织病变加重,纤维化占比增加(P<0.05),血清肾功能指标、炎性因子水平及肾脏组织α-SMA、snail、FDX1表达上升(P<0.05),E-cadherin、ALKBH5表达下降(P<0.05)。与LV5-vector组相比,LV5-ALKBH5组小鼠的上述指标结果明显改善(P<0.05),且ALKBH5的过表达减轻了FDX1激活对UUO小鼠肾脏组织炎性反应、EMT及肾间质纤维化的促进作用。结论 ALKBH5可能通过下调铜死亡相关基因Fdx1的表达,减轻炎性反应,抑制EMT,改善UUO小鼠的肾脏损伤,缓解RIF。

关键词: 单侧输尿管梗阻, 肾间质纤维化, 烷化修复同源物5(ALKBH5), 铁氧还蛋白1(FDX1), 铜死亡

Abstract: Objective To explore the effect of alkylated repair(RNA demethylase ALKB) homologue 5 (ALKBH5) to regulate the expression of cuproptosis-related gene ferredoxin 1 (Fdx1) on renal interstitial fibrosis (RIF) in unilateral ureteral obstruction (UUO) mice. Methods The UUO model mice were randomly divided into a model group (UUO group), a negative control group (LV5-vector group), an ALKBH5 over-expression group (LV5-ALKBH5 group), an LV5-vector+ FDX1 activator (Elesclomol) group and an LV5-ALKBH5+Elesclomol group, with 12 mice in each .Another 12 healthy mice were taken as control group (control group). ELISA kit was used to detect serum inflammatory factor; HE and Masson staining microscopy was used to observe renal histopathological changes and fibrosis; RT-qPCR detection of epithelial-mesenchymal transition (EMT)-related genes and Alkbh5 and Fdx1 mRNA expression in renal tissue epithelial cells; The expression of ALKBH5 and FDX1 protein were detected by immunoblotting. Results Compared with the control group, mice in the UUO group showed increased renal tissue lesions, increased percentage of fibrosis (P<0.05), increased serum renal function indexes; Higher level of inflammation factor and renal tissue α-SMA, snail and FDX1 expression (P<0.05), and decreased E-cadherin and ALKBH5 expression (P<0.05).Compared with the LV5-vector group, mice in the LV5-ALKBH5 group showed significantly improved results on above indexes (P<0.05). Over-expression of ALKBH5 was reversed which promoted FDX1 activation on renal tissue inflammation, EMT and renal interstitial fibrosis in UUO mice. Conclusions ALKBH5 may attenuate the inflammatory response, inhibit EMT, ameliorate kidney injury, and alleviate RIF in UUO mice by down-regulating the expression of the cuproptosis-related gene Fdx1.

Key words: unilateral ureteral obstruction, renal interstitial fibrosis, alkylated repair homologue 5 (ALKBH5), ferredoxin 1 (FDX1), cuproptosis

中图分类号: